Cargando…

Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort

AIM: To examine patient-centered outcomes with vasopressin (AVP) use in patients with cirrhosis with catecholamine-refractory septic shock. METHODS: We conducted a single center, retrospective cohort study enrolling adult patients with cirrhosis treated for catecholamine-resistant septic shock in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myc, Lukasz A, Stine, Jonathan G, Chakrapani, Rinita, Kadl, Alexandra, Argo, Curtis K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241528/ https://www.ncbi.nlm.nih.gov/pubmed/28144392 http://dx.doi.org/10.4254/wjh.v9.i2.106

Ejemplares similares

The effect of vasopressin on gastric perfusion in catecholamine-dependent septic shock patients
por: van Haren, FMP, et al.
Publicado: (2003)

Efficacy and Safety of Vasopressin Alone or in Combination With Catecholamines in the Treatment of Septic Shock: A Systematic Review
por: Mandal, Naishal, et al.
Publicado: (2022)

Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury
por: Meyer, Sascha, et al.
Publicado: (2006)

Terlipressin in the treatment of catecholamine resistant septic shock
por: Auzinger, GM, et al.
Publicado: (2002)

Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis
por: Yao, Ren-qi, et al.
Publicado: (2020)

Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis
por: Stine, Jonathan G, et al.
Publicado: (2017)

Potential for overuse of corticosteroids and vasopressin in septic shock
por: Hsu, Joe L, et al.
Publicado: (2012)

Use of vasopressin in the treatment of refractory septic shock
por: Kny, Katiuce Tomazi, et al.
Publicado: (2018)

Catecholamines/propofol/vasopressin: Hypertriglyceridaemia: case report
Publicado: (2020)

Clinical review: Vasopressin and terlipressin in septic shock patients
por: Delmas, Anne, et al.
Publicado: (2005)

Dear vasopressin, where is your place in septic shock?
por: Duenser, Martin W, et al.
Publicado: (2005)

Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009)

Bench-to-bedside review: Vasopressin in the management of septic shock
por: Russell, James A
Publicado: (2011)

The apelinergic system as an alternative to catecholamines in low-output septic shock
por: Coquerel, David, et al.
Publicado: (2018)

Catecholamine pharmacokinetics and pharmacodynamics in critical illness
por: Johnston, AJ, et al.
Publicado: (2003)

Using terlipressin in a pediatric patient with septic shock resistant to catecholamines
por: Erdogan, Seher, et al.
Publicado: (2017)

Effect of synthetic vasopressin in septic shock using eosphageal Doppler
por: Elatroush, H, et al.
Publicado: (2010)

Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
por: Mehta, Sangeeta, et al.
Publicado: (2013)

Vasopressin substitution causes microcirculatory changes in patients with septic shock
por: Klinzing, S, et al.
Publicado: (2007)

Vasopressin versus norepinephrine for the management of septic shock in cancer patients
por: Zambolim, C, et al.
Publicado: (2014)

Hemodynamic effects of association of vasopressin and norepinephrine in patients with septic shock
por: Fathallah, B, et al.
Publicado: (2008)

When to start vasopressin in septic shock: the strategy we propose
por: Guerci, Philippe, et al.
Publicado: (2022)

Epinephrine kinetics in septic shock – a means to understand variable catecholamine efficiency?
por: Calzia, Enrico, et al.
Publicado: (2009)

Appropriate fluid resuscitation of septic shock patients pretreated with high doses of catecholamines
por: Lewejohann, JC, et al.
Publicado: (2015)

Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow
por: Krejci, Vladimir, et al.
Publicado: (2007)

Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study
por: Morelli, A, et al.
Publicado: (2008)

Vasopressin and terlipressin as first-line therapy in fulminant ovine septic shock
por: Rehberg, S, et al.
Publicado: (2008)

Predictors of response to fixed-dose vasopressin in adult patients with septic shock
por: Sacha, Gretchen L., et al.
Publicado: (2018)

Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
por: Mehta, Sangeeta, et al.
Publicado: (2017)

Successful Use of Methylene Blue in Catecholamine-Resistant Septic Shock: A Case Report and Short Literature Review
por: Pluta, Michał P., et al.
Publicado: (2023)

Adrenomedullin blockade improves catecholamine responsiveness and kidney function in resuscitated murine septic shock
por: Wagner, K, et al.
Publicado: (2012)

Importance of adequate fluid resuscitation in patients with severe septic shock on high catecholamine doses
por: Lewejohann, J, et al.
Publicado: (2008)

Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock
por: Wagner, Katja, et al.
Publicado: (2013)

Hepato-splanchnic and pancreatic blood flow during administration of vasopressin in septic shock
por: Krejci, V, et al.
Publicado: (2003)

Effects of vasopressin and terlipressin in ovine septic shock on mesenteric blood flow and survival
por: Rehberg, Sebastian, et al.
Publicado: (2007)

Glucose metabolism during hyperdynamic septic shock: comparison between noradrenaline and vasopressin
por: Hauser, B, et al.
Publicado: (2008)

Vasopressin in Septic Shock; Assessment of Sepsis Biomarkers: A Randomized, Controlled Trial
por: Barzegar, Elchin, et al.
Publicado: (2017)

Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock
por: Kreü, Simon, et al.
Publicado: (2017)

Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock
por: Kim, Jin Joo, et al.
Publicado: (2019)

Serum lactate levels in cirrhosis and non-cirrhosis patients with septic shock
por: Tongyoo, Surat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_si7qkpqoma8b122nn8h9p434a9